Erez Chimovits serves as Executive at LogicBio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Erez Chimovits has executed 17 insider transactions totaling $16.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 12, 2021 involved receiving (via award) 420,299 shares valued at $5.5M.
Erez Chimovits currently holds 5,243,259 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erez Chimovits has been a net buyer of LOGC stock. They have purchased $16.0M and sold $0 worth of shares.
Erez Chimovits's most recent insider trade was on Feb 12, 2021, when they sold 420,299 shares at $13.00 per share.
Get notified when new Form 4 filings are submitted
| $13.00 |
| Discretionary |
| Oct 1, 2020 | LOGC | $1.8M | Purchase | 296,296 | $6.00 | Discretionary |
| Oct 1, 2020 | LOGC | $3.8M | Purchase | 639,212 | $6.00 | Discretionary |
| Oct 1, 2020 | LOGC | $3.3M | Purchase | 545,974 | $6.00 | Discretionary |
| Sep 15, 2020 | ACET | $0 | Award | 902,885 | $N/A | Discretionary |
| Sep 15, 2020 | ACET | $0 | Award | 292,607 | $N/A | Discretionary |
| Dec 19, 2019 | PHGE | $31.1K | Purchase | 3,500 | $8.90 | Discretionary |
| Dec 18, 2019 | PHGE | $4.5K | Purchase | 500 | $8.93 | Discretionary |
| Dec 11, 2019 | PHGE | $48.2K | Purchase | 5,400 | $8.92 | Discretionary |
| Dec 10, 2019 | PHGE | $29.8K | Purchase | 3,400 | $8.75 | Discretionary |
| Dec 9, 2019 | PHGE | $52.1K | Purchase | 6,000 | $8.68 | Discretionary |
| Dec 6, 2019 | PHGE | $6.4K | Purchase | 800 | $8.00 | Discretionary |
| Dec 5, 2019 | PHGE | $27.2K | Purchase | 3,400 | $7.99 | Discretionary |
| May 2, 2019 | NVUS | $2.0M | Purchase | 646,204 | $3.10 | Discretionary |
| Oct 23, 2018 | LOGC | $4.9M | Purchase | 490,000 | $10.00 | Discretionary |
| Oct 23, 2018 | LOGC | $0 | Conversion | 2,997,760 | $N/A | Discretionary |